Christine Marie Hunt
Adjunct Professor in the Department of Medicine
Current Appointments & Affiliations
- Adjunct Professor in the Department of Medicine, Medicine, Gastroenterology, Medicine 2019
Contact Information
- 00550 Hosp South, Durham, NC 27710
- Box 3913 Med Ctr, Durham, NC 27710
-
(919) 684-8111
- Background
-
Education, Training, & Certifications
- M.P.H., University of North Carolina - Chapel Hill 2013
- M.D., Boston University School of Medicine 1982
-
Previous Appointments & Affiliations
- Adjunct Associate Professor in the Department of Medicine, Medicine, Gastroenterology, Medicine 2017 - 2019
- Adjunct Associate Professor in the Department of Medicine, Medicine, Gastroenterology, Medicine 2010 - 2017
- Assistant Consulting Professor of Medicine, Medicine, Gastroenterology, Medicine 1996 - 2003
- Assistant Professor of Medicine, Medicine, Gastroenterology, Medicine 1988 - 1996
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Hunt, Christine M., Tae Hoon Lee, Timothy R. Morgan, and Sheldon Campbell. “One Alanine Aminotransferase Is Not Like the Other.” Gastroenterology, April 23, 2023. https://doi.org/10.1053/j.gastro.2023.04.009.Full Text Link to Item
-
Alpers, David H., James H. Lewis, Christine M. Hunt, James W. Freston, Vicente E. Torres, Hui Li, Wenchyi Wang, et al. “Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical Trials.” Am J Kidney Dis 81, no. 3 (March 2023): 281-293.e1. https://doi.org/10.1053/j.ajkd.2022.08.012.Full Text Link to Item
-
Suzuki, Ayako, Hans Tillmann, James Williams, Ronald G. Hauser, Julie Frund, Mizuki Suzuki, Fred Prior, et al. “Assessment of the Frequency, Phenotypes, and Outcomes of Acute Liver Injury Associated with Amoxicillin/Clavulanate in 1.4 Million Patients in the Veterans Health Administration.” Drug Saf 46, no. 2 (February 2023): 129–43. https://doi.org/10.1007/s40264-022-01255-3.Full Text Link to Item
-
Hunt, Christine M., Jimmy T. Efird, Thomas S. Redding, Andrew D. Thompson, Ashlyn M. Press, Christina D. Williams, Christopher J. Hostler, and Ayako Suzuki. “Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans.” J Gen Intern Med 37, no. 16 (December 2022): 4144–52. https://doi.org/10.1007/s11606-022-07701-3.Full Text Link to Item
-
Lee, Tzu-Hao, Christine M. Hunt, Marissa M. Maier, Elliott Lowy, and Lauren A. Beste. “Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.” Clin Infect Dis 75, no. 9 (October 29, 2022): 1529–36. https://doi.org/10.1093/cid/ciac227.Full Text Link to Item
-
Tuteja, Sony, Zhihong Yu, Otis Wilson, Hua-Chang Chen, Frank Wendt, Cecilia P. Chung, Shailja C. Shah, et al. “Pharmacogenetic variants and risk of remdesivir-associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID-19.” Clin Transl Sci 15, no. 8 (August 2022): 1880–86. https://doi.org/10.1111/cts.13313.Full Text Link to Item
-
Shah, Shailja, Alese Halvorson, Brandon McBay, Chad Dorn, Otis Wilson, Sony Tuteja, Kyong-Mi Chang, et al. “Proton-pump inhibitor use is not associated with severe COVID-19-related outcomes: a propensity score-weighted analysis of a national veteran cohort.” Gut 71, no. 7 (July 2022): 1447–50. https://doi.org/10.1136/gutjnl-2021-325701.Full Text Link to Item
-
Hung, Adriana M., Shailja C. Shah, Alexander G. Bick, Zhihong Yu, Hua-Chang Chen, Christine M. Hunt, Frank Wendt, et al. “APOL1 Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program.” Jama Intern Med 182, no. 4 (April 1, 2022): 386–95. https://doi.org/10.1001/jamainternmed.2021.8538.Full Text Link to Item
-
Dominitz, Jason A., Deborah A. Fisher, Katherine S. Garman, Christine M. Hunt, David Lieberman, Andrew J. Muir, Jane E. Onken, Douglas J. Robertson, Robert S. Sandler, and Shahnaz Sultan. “In Memoriam: Dawn Tranchino Provenzale, MD, MS (August 18, 1955-April 20, 2021).” Gastroenterology, December 22, 2021. https://doi.org/10.1053/j.gastro.2021.12.258.Full Text Open Access Copy Link to Item
-
Suzuki, Ayako, Jimmy T. Efird, Thomas S. Redding, Andrew D. Thompson, Ashlyn M. Press, Christina D. Williams, Christopher J. Hostler, and Christine M. Hunt. “COVID-19-Associated Mortality in US Veterans with and without SARS-CoV-2 Infection.” Int J Environ Res Public Health 18, no. 16 (August 11, 2021). https://doi.org/10.3390/ijerph18168486.Full Text Open Access Copy Link to Item
-
Beste, Lauren A., Michael Icardi, Christine M. Hunt, Ina Gylys-Colwell, Elliott Lowy, Leslie Taylor, Timothy R. Morgan, Michael F. Chang, Marissa M. Maier, and Ramsey Cheung. “In Reply.” Arch Pathol Lab Med 145, no. 2 (February 1, 2021): 129b – 1130. https://doi.org/10.5858/arpa.2020-0643-LE.Full Text Link to Item
-
Glass, Lisa M., Christine M. Hunt, Michael Fuchs, and Grace L. Su. “Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both?” Fed Pract 36, no. 2 (February 2019): 64–71.Link to Item
-
Hunt, Christine M., Marsha J. Turner, Elizabeth J. Gifford, Rachel B. Britt, and Grace L. Su. “Identifying and Treating Nonalcoholic Fatty Liver Disease.” Fed Pract 36, no. 1 (January 2019): 20–29.Link to Item
-
Patel, Yuval A., Elizabeth J. Gifford, Lisa M. Glass, Marsha J. Turner, Byungjoo Han, Cynthia A. Moylan, Steve Choi, Ayako Suzuki, Dawn Provenzale, and Christine M. Hunt. “Correction to: Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.” Dig Dis Sci 63, no. 10 (October 2018): 2813–14. https://doi.org/10.1007/s10620-018-5213-2.Full Text Open Access Copy Link to Item
-
Jasmine Bullard, A., Francesca E. Cunningham, Bryan D. Volpp, Elliott Lowy, Lauren A. Beste, Bernadette B. Heron, Mark Geraci, et al. “Preventing Hepatitis B Reactivation During Anti-CD20 Antibody Treatment in the Veterans Health Administration.” Hepatol Commun 2, no. 9 (September 2018): 1136–46. https://doi.org/10.1002/hep4.1238.Full Text Open Access Copy Link to Item
-
Patel, Yuval A., Elizabeth J. Gifford, Lisa M. Glass, Marsha J. Turner, Byungjoo Han, Cynthia A. Moylan, Steve Choi, Ayako Suzuki, Dawn Provenzale, and Christine M. Hunt. “Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.” Dig Dis Sci 63, no. 9 (September 2018): 2259–66. https://doi.org/10.1007/s10620-018-5123-3.Full Text Link to Item
-
George, Nayana, Minjun Chen, Nancy Yuen, Christine M. Hunt, and Ayako Suzuki. “Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury.” Regul Toxicol Pharmacol 94 (April 2018): 101–7. https://doi.org/10.1016/j.yrtph.2018.01.018.Full Text Link to Item
-
Hunt, Christine M. “Expanding our toolkit to better identify drug-induced liver injury in electronic medical records.” Liver Int 38, no. 4 (April 2018): 585–87. https://doi.org/10.1111/liv.13710.Full Text Link to Item
-
Patel, Y. A., and C. M. Hunt. “Editorial: diabetes, obesity and clinical inertia-the recipe for advanced NASH. Authors' reply.” Aliment Pharmacol Ther 47, no. 8 (April 2018): 1221–22. https://doi.org/10.1111/apt.14505.Full Text Link to Item
-
Patel, Y. A., E. J. Gifford, L. M. Glass, R. McNeil, M. J. Turner, B. Han, D. Provenzale, S. S. Choi, C. A. Moylan, and C. M. Hunt. “Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.” Aliment Pharmacol Ther 47, no. 2 (January 2018): 268–78. https://doi.org/10.1111/apt.14411.Full Text Link to Item
-
Hunt, Christine M., Julie I. Papay, Vid Stanulovic, and Arie Regev. “Drug rechallenge following drug-induced liver injury.” Hepatology 66, no. 2 (August 2017): 646–54. https://doi.org/10.1002/hep.29152.Full Text Link to Item
-
Lynch, Julie, Scott L. DuVall, Brygida Berse, Angela Whatley, Cathy St Pierre, Omobonike Oloruntoba, and Christine M. Hunt. “Implementation of Pharmacogenetic Testing Within the Veterans Health Administration From 2011 to 2013.” Mil Med 181, no. 10 (October 2016): 1375–81. https://doi.org/10.7205/MILMED-D-15-00523.Full Text Link to Item
-
Shantakumar, Sumitra, Sarah Landis, Andy Lawton, and Christine M. Hunt. “Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort.” Regul Toxicol Pharmacol 77 (June 2016): 257–62. https://doi.org/10.1016/j.yrtph.2016.03.019.Full Text Open Access Copy Link to Item
-
Hunt, Christine M., Lauren A. Beste, Elliott Lowy, Ayako Suzuki, Cynthia A. Moylan, Hans L. Tillmann, George N. Ioannou, Joseph K. Lim, Michael J. Kelley, and Dawn Provenzale. “Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.” World J Gastroenterol 22, no. 19 (May 21, 2016): 4732–40. https://doi.org/10.3748/wjg.v22.i19.4732.Full Text Open Access Copy Link to Item
-
Stirnadel-Farrant, Heide A., Nicholas Galwey, Chanchal Bains, Caroline Yancey, and Christine M. Hunt. “Children's liver chemistries vary with age and gender and require customized pediatric reference ranges.” Regul Toxicol Pharmacol 73, no. 1 (October 2015): 349–55. https://doi.org/10.1016/j.yrtph.2015.07.013.Full Text Link to Item
-
Suzuki, A., N. A. Yuen, K. Ilic, R. T. Miller, M. J. Reese, H. R. Brown, J. I. Ambroso, J. G. Falls, and C. M. Hunt. “Corrigendum to "Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBaseTM" [Regul. Toxicol. Pharmacol. (2015) 481-490] doi: 10.1016/j.yrtph.2015.05.004.” Regulatory Toxicology and Pharmacology 73, no. 1 (October 1, 2015): 348. https://doi.org/10.1016/j.yrtph.2015.07.020.Full Text
-
Suzuki, Ayako, Nancy A. Yuen, Katarina Ilic, Richard T. Miller, Melinda J. Reese, H Roger Brown, Jeffrey I. Ambroso, J Gregory Falls, and Christine M. Hunt. “Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™.” Regul Toxicol Pharmacol 72, no. 3 (August 2015): 481–90. https://doi.org/10.1016/j.yrtph.2015.05.004.Full Text Link to Item
-
Hunt, Christine M., Nancy A. Yuen, Heide A. Stirnadel-Farrant, and Ayako Suzuki. “Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database.” Regul Toxicol Pharmacol 70, no. 2 (November 2014): 519–26. https://doi.org/10.1016/j.yrtph.2014.09.007.Full Text Link to Item
-
Cheetham, T Craig, Janet Lee, Christine M. Hunt, Fang Niu, Steph Reisinger, Rich Murray, Greg Powell, and Julie Papay. “An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.” Pharmacoepidemiol Drug Saf 23, no. 6 (June 2014): 601–8. https://doi.org/10.1002/pds.3531.Full Text Link to Item
-
Spraggs, Colin F., Chun-Fang Xu, and Christine M. Hunt. “Genetic characterization to improve interpretation and clinical management of hepatotoxicity caused by tyrosine kinase inhibitors.” Pharmacogenomics 14, no. 5 (April 2013): 541–54. https://doi.org/10.2217/pgs.13.24.Full Text Link to Item
-
Shin, Janet, Christine M. Hunt, Ayako Suzuki, Julie I. Papay, Kathleen J. Beach, and T Craig Cheetham. “Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data.” Pharmacoepidemiol Drug Saf 22, no. 2 (February 2013): 190–98. https://doi.org/10.1002/pds.3388.Full Text Link to Item
-
Moylan, Cynthia A., Ayako Suzuki, Julie I. Papay, Nancy A. Yuen, Michael Ames, and Christine M. Hunt. “A pre-marketing ALT signal predicts post-marketing liver safety.” Regul Toxicol Pharmacol 63, no. 3 (August 2012): 433–39. https://doi.org/10.1016/j.yrtph.2012.05.016.Full Text Link to Item
-
Hunt, Christine M., Julie I. Papay, Donna S. Rich, Christopher J. Abissi, and Mark W. Russo. “The evaluation of drug rechallenge: the casopitant Phase III program.” Regul Toxicol Pharmacol 58, no. 3 (December 2010): 539–43. https://doi.org/10.1016/j.yrtph.2010.09.014.Full Text Link to Item
-
Hunt, Christine M. “Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: a systematic review.” Hepatology 52, no. 6 (December 2010): 2216–22. https://doi.org/10.1002/hep.24022.Full Text Link to Item
-
Suzuki, Ayako, Raul J. Andrade, Einar Bjornsson, M Isabel Lucena, William M. Lee, Nancy A. Yuen, Christine M. Hunt, and James W. Freston. “Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.” Drug Saf 33, no. 6 (June 1, 2010): 503–22. https://doi.org/10.2165/11535340-000000000-00000.Full Text Link to Item
-
Suzuki, Ayako, Nancy Yuen, John Walsh, Julie Papay, Christine M. Hunt, and Anna Mae Diehl. “Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophen-associated liver injury.” Clin Gastroenterol Hepatol 7, no. 8 (August 2009): 882–88. https://doi.org/10.1016/j.cgh.2009.03.034.Full Text Link to Item
-
Hunt, Christine M., Julie I. Papay, Rita I. Edwards, Dickens Theodore, David H. Alpers, Colin Dollery, Tjerk W. Debruin, Kimberly K. Adkison, Heide A. Stirnadel, and Trevor G. Gibbs. “Monitoring liver safety in drug development: the GSK experience.” Regul Toxicol Pharmacol 49, no. 2 (November 2007): 90–100. https://doi.org/10.1016/j.yrtph.2007.06.002.Full Text Link to Item
-
Hunt, C. M., J. M. McGill, M. I. Allen, and L. D. Condreay. “Clinical relevance of hepatitis B viral mutations.” Hepatology 31, no. 5 (May 2000): 1037–44. https://doi.org/10.1053/he.2000.6709.Full Text Link to Item
-
Stave, G. M., J. J. Mignogna, G. S. Powell, and C. M. Hunt. “Evaluation of a workplace hemochromatosis screening program.” Am J Prev Med 16, no. 4 (May 1999): 303–6. https://doi.org/10.1016/s0749-3797(99)00018-5.Full Text Link to Item
-
Hunt, C. M., and A. I. Sharara. “Liver disease in pregnancy.” Am Fam Physician 59, no. 4 (February 15, 1999): 829–36.Link to Item
-
Lamps, L. W., C. M. Hunt, A. Green, G. F. Gray, and K. Washington. “Alterations in colonic mucosal vessels in patients with cirrhosis and noncirrhotic portal hypertension.” Hum Pathol 29, no. 5 (May 1998): 527–35. https://doi.org/10.1016/s0046-8177(98)90071-5.Full Text Link to Item
-
Hunt, C. M., C. A. Camargo, J. A. Dominitz, B. P. Bute, and P. M. Clavien. “Effect of postoperative complications on health and employment following liver transplantation.” Clin Transplant 12, no. 2 (April 1998): 99–103.Link to Item
-
Hunt, C. M., C. A. Camargo, J. A. Dominitz, B. P. Bute, and P. M. Clavien. “Effect of postoperative complications on health and employment following liver transplantation.” Clinical Transplantation 12, no. 2 (April 1, 1998): 105–9.
-
Hunt, C. M., J. A. Dominitz, B. P. Bute, B. Waters, U. Blasi, and D. M. Williams. “Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life.” Dig Dis Sci 42, no. 12 (December 1997): 2482–86. https://doi.org/10.1023/a:1018852309885.Full Text Link to Item
-
Carson, K. L., and C. M. Hunt. “Medical problems occurring after orthotopic liver transplantation.” Dig Dis Sci 42, no. 8 (August 1997): 1666–74. https://doi.org/10.1023/a:1018853213442.Full Text Link to Item
-
Hunt, C. M., K. L. Carson, and T. L. Ortel. “Combined factor IX and XI deficiency discovered at liver biopsy.” Dig Dis Sci 42, no. 8 (August 1997): 1731–33. https://doi.org/10.1023/a:1018821701147.Full Text Link to Item
-
Sharara, Ala I. “Hepatitis C and Cancer.” Annals of Internal Medicine 126, no. 12 (June 15, 1997): 1003–1003. https://doi.org/10.7326/0003-4819-126-12-199706150-00023.Full Text
-
Hunt, C. M., K. L. Carson, and A. I. Sharara. “Hepatitis C in pregnancy.” Obstet Gynecol 89, no. 5 Pt 2 (May 1997): 883–90. https://doi.org/10.1016/s0029-7844(97)81434-2.Full Text Link to Item
-
Carson, K., M. K. Washington, W. R. Treem, P. A. Clavien, and C. M. Hunt. “Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient.” Liver Transpl Surg 3, no. 2 (March 1997): 174–76. https://doi.org/10.1002/lt.500030211.Full Text Link to Item
-
Lamps, L. W., C. M. Hunt, and K. Washington. “Alterations in colonic mucosal vessels in patients with portal hypertension.” Laboratory Investigation 76, no. 1 (January 1, 1997): 330–330.Link to Item
-
Sharara, A. I., C. M. Hunt, and J. D. Hamilton. “Hepatitis C.” Ann Intern Med 125, no. 8 (October 15, 1996): 658–68. https://doi.org/10.7326/0003-4819-125-8-199610150-00006.Full Text Link to Item
-
Carson, K. L., T. T. Tran, P. Cotton, A. I. Sharara, and C. M. Hunt. “Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease.” Am J Gastroenterol 91, no. 5 (May 1996): 1022–23.Link to Item
-
Hunt, C. M., J. S. Tart, E. Dowdy, B. P. Bute, D. M. Williams, and P. A. Clavien. “Effect of orthotopic liver transplantation on employment and health status.” Liver Transpl Surg 2, no. 2 (March 1996): 148–53. https://doi.org/10.1002/lt.500020211.Full Text Link to Item
-
McGill, J. M., D. M. Williams, and C. M. Hunt. “Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis.” Dig Dis Sci 41, no. 3 (March 1996): 540–42. https://doi.org/10.1007/BF02282335.Full Text Link to Item
-
CAMARGO, C. A., C. M. HUNT, and P. A. CLAVIEN. “THE EFFECTS OF POSTOPERATIVE COMPLICATIONS ON QUALITY-OF-LIFE PARAMETERS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION.” Hepatology 22, no. 4 (October 1, 1995): 140–140.Link to Item
-
HUNT, C. M., J. S. TART, E. DOWDY, B. P. BUTE, and D. M. WILLIAMS. “EFFECT OF ORTHOTOPIC LIVER-TRANSPLANTATION ON EMPLOYMENT AND HEALTH-STATUS.” Gastroenterology 108, no. 4 (April 1, 1995): A18–A18.Link to Item
-
Maniatis, A. G., and C. M. Hunt. “Therapy for spontaneous umbilical hernia rupture.” Am J Gastroenterol 90, no. 2 (February 1995): 310–12.Link to Item
-
Hunt, C. M., and K. Washington. “Tetracycline-induced bile duct paucity and prolonged cholestasis.” Gastroenterology 107, no. 6 (December 1994): 1844–47. https://doi.org/10.1016/0016-5085(94)90830-3.Full Text Link to Item
-
Todd, N. W., C. M. Hunt, T. P. Kennedy, C. A. Piantadosi, and A. R. Whorton. “Effects of inhibition and induction of cytochrome P-450 isozymes on hyperoxic lung injury in rats.” Am J Respir Cell Mol Biol 7, no. 2 (August 1992): 222–29. https://doi.org/10.1165/ajrcmb/7.2.222.Full Text Link to Item
-
Hunt, C. M., W. R. Westerkam, and G. M. Stave. “Effect of age and gender on the activity of human hepatic CYP3A.” Biochem Pharmacol 44, no. 2 (July 22, 1992): 275–83. https://doi.org/10.1016/0006-2952(92)90010-g.Full Text Link to Item
-
Hunt, C. M., W. R. Westerkam, G. M. Stave, and J. A. Wilson. “Hepatic cytochrome P-4503A (CYP3A) activity in the elderly.” Mech Ageing Dev 64, no. 1–2 (June 1992): 189–99. https://doi.org/10.1016/0047-6374(92)90106-n.Full Text Link to Item
-
Hunt, C. M., P. B. Watkins, P. Saenger, G. M. Stave, N. Barlascini, C. O. Watlington, J. T. Wright, and P. S. Guzelian. “Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol.” Clin Pharmacol Ther 51, no. 1 (January 1992): 18–23. https://doi.org/10.1038/clpt.1992.3.Full Text Link to Item
-
Hunt, C. M., P. S. Guzelian, D. T. Molowa, and S. A. Wright. “Regulation of rat hepatic cytochrome P450IIE1 in primary monolayer hepatocyte culture.” Xenobiotica 21, no. 12 (December 1991): 1621–31. https://doi.org/10.3109/00498259109044410.Full Text Link to Item
-
WESTERKAM, W. R., J. A. P. WILSON, and C. M. HUNT. “HUMAN HEPATIC CYTOCHROME P-450IIIA ACTIVITY IN THE ELDERLY.” Journal of the American Geriatrics Society 39, no. 8 (August 1, 1991): A17–A17.Link to Item
-
Hunt, C. M., S. Strater, and G. M. Stave. “Effect of normal aging on the activity of human hepatic cytochrome P450IIE1.” Biochem Pharmacol 40, no. 7 (October 1, 1990): 1666–69. https://doi.org/10.1016/0006-2952(90)90470-6.Full Text Link to Item
-
-
Conference Papers
-
Beste, Lauren A., Michael Icardi, Christine M. Hunt, Ina Gylys-Colwell, Elliott Lowy, Leslie Taylor, Timothy R. Morgan, Michael F. Chang, Marissa M. Maier, and Ramsey Cheung. “Alanine Aminotransferase Results Differ by Analyzer Manufacturer in a National Integrated Health Setting, 2012-2017.” In Arch Pathol Lab Med, 144:748–54, 2020. https://doi.org/10.5858/arpa.2018-0622-OA.Full Text Link to Item
-
Beste, Lauren A., Tzu-Hao Lee, Elliott Lowy, Christine M. Hunt, Shari S. Rogel, Jasmohan S. Bajaj, Ina Gylys-Colwell, Maggie Chartier, and Timothy R. Morgan. “OPPORTUNITIES FOR EARLY DIAGNOSIS OF UNRECOGNIZED CIRRHOSIS IN THE DEPARTMENT OF VETERANS AFFAIRS.” In Hepatology, 72:399A-400A, 2020.Link to Item
-
Lee, Tzu-Hao, Christine M. Hunt, Marissa Maier, Elliott Lowy, and Lauren A. Beste. “QUALITY OF HEPATITIS B VIRUS-RELATED CARE IN PATIENTS WITH HBV MONOINFECTION AND HBV/HIV COINFECTION UNDER GI OR ID CARE: A NATIONAL VHA COHORT STUDY.” In Hepatology, 72:407A-407A, 2020.Link to Item
-
Voils, Corrine, Heather King, Daniel Blalock, Carolyn T. Thorpe, Ian Kronish, Bryce Reeve, Christine M. Hunt, Colleen Boatright, Jamiyla Bolton, and Ziad F. Gellad. “CHARACTERIZING ADHERENCE TO DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C INFECTION.” In Gastroenterology, 154:S1228–S1228. W B SAUNDERS CO-ELSEVIER INC, 2018.Link to Item
-
Tillmann, H., C. M. Hunt, M. Austen, J. Williams, and A. Suzuki. “Early and late liver-related mortality following drug induced liver injury from amoxicillin-clavulanate.” In Journal of Hepatology, 68:S70–S70. Elsevier BV, 2018. https://doi.org/10.1016/s0168-8278(18)30360-x.Full Text
-
Patel, Yuval A., Elizabeth Gifford, Lisa M. Glass, Rebecca McNeil, Marsha J. Turner, Byungjoo Han, Dawn T. Provenzale, Steve S. Choi, Cynthia A. Moylan, and Christine M. Hunt. “Diet/exercise programs are used by only one in five severely obese patients with biopsy-defined Nonalcoholic Fatty Liver Disease (NAFLD) advanced fibrosis in the Veterans Health Administration (VHA).” In Hepatology, 66:1164A-1164A. WILEY, 2017.Link to Item
-
Suzuki, Ayako, Mark A. Austen, James S. Williams, Hans L. Tillmann, and Christine M. Hunt. “Higher rates and significant disparities in the risk and phenotypes of amoxicillin:clavulanate-related liver injury were observed in the Veterans Health Administration (VHA).” In Hepatology, 66:425A-425A. WILEY, 2017.Link to Item
-
Hunt, Christine M., Lauren A. Beste, George N. Ioannou, Elliott Lowy, Dawn T. Provenzale, Michael J. Kelley, Ayako Suzuki, et al. “Hepatitis B Testing Prior to Administration of Rituximab, Ofatumumab and Obinutuzumab in the National Veterans Affairs Health Healthcare System, 2002-2014.” In Hepatology, 62:478A-479A. WILEY-BLACKWELL, 2015.Link to Item
-
Suzuki, Ayako, Nancy A. Yuen, Katarina Ilic, and Christine M. Hunt. “DRUG-INDUCED LIVER INJURY (DILI) MODULATED BY CONCOMITANT USE OF TARGETED DRUG CLASSES: AN ANALYSIS OF 303 DRUGS ASSOCIATED WITH HEPATOTOXICITY.” In Hepatology, 54:523A-524A. WILEY-BLACKWELL, 2011.Link to Item
-
Suzuki, Ayako, Nancy A. Yuen, Katarina Ilic, and Christine M. Hunt. “IMPACT OF CONCOMITANT MEDICATIONS ON DRUG-INDUCED LIVER INJURY: DATA MINING ANALYSIS USING THE WHO VIGIBASE (TM) DATABASE.” In Hepatology, 54:523A-523A. WILEY-BLACKWELL, 2011.Link to Item
-
Suzuki, Ayako, Raul J. Andrade, Einar Bjornsson, M. I. Lucena, Nancy A. Yuen, Christine M. Hunt, and James W. Freston. “INTERNATIONAL COLLABORATIVE WORK: A UNIFIED LIST OF DRUGS ASSOCIATED WITH HEPATOTOXICITY AND THE REPORTING FREQUENCY OF LIVER EVENTS IN THE WHO.” In Hepatology, 50:425A-425A. JOHN WILEY & SONS INC, 2009.Link to Item
-
Suzuki, Ayako, Nancy A. Yuen, John S. Walsh, Kim K. Adkison, Julie I. Papay, Katarino Ilic, Anna Mae Diehl, and Christine M. Hunt. “POSSIBLE MODULATION OF ACETAMINOPHEN-ASSOCIATED LIVER INJURY BY DIVERSE CO-MEDICATIONS IN THE AERS DATABASE - A QUANTITATIVE SIGNAL DETECTION ANALYSIS.” In Hepatology, 48:471A-472A. JOHN WILEY & SONS INC, 2008.Link to Item
-
Suzuki, Ayako, Nancy A. Yuen, Julie I. Papay, John S. Walsh, Christine M. Hunt, and Anna Mae Diehl. “An aers database evaluation of the influence of co-medications on acetaminophen-associated liver injury.” In Gastroenterology, 134:A758–59, 2008.Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.